1. Home
  2. TGTX vs CAG Comparison

TGTX vs CAG Comparison

Compare TGTX & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$49.93

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo ConAgra Brands Inc.

CAG

ConAgra Brands Inc.

HOLD

Current Price

$14.98

Market Cap

6.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGTX
CAG
Founded
1993
1919
Country
United States
United States
Employees
N/A
26100
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.9B
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
TGTX
CAG
Price
$49.93
$14.98
Analyst Decision
Strong Buy
Hold
Analyst Count
5
17
Target Price
$49.80
$16.88
AVG Volume (30 Days)
2.3M
13.1M
Earning Date
05-04-2026
04-01-2026
Dividend Yield
N/A
9.84%
EPS Growth
1746.67
N/A
EPS
0.17
N/A
Revenue
$2,785,000.00
$1,500,000,000.00
Revenue This Year
$49.08
N/A
Revenue Next Year
$26.69
N/A
P/E Ratio
$293.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.76
$12.53
52 Week High
$59.30
$20.32

Technical Indicators

Market Signals
Indicator
TGTX
CAG
Relative Strength Index (RSI) 44.73 51.80
Support Level $45.37 $13.47
Resistance Level $58.08 $15.89
Average True Range (ATR) 2.12 0.38
MACD -0.51 -0.06
Stochastic Oscillator 38.04 24.60

Price Performance

Historical Comparison
TGTX
CAG

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

About CAG ConAgra Brands Inc.

Conagra Brands Inc is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). The majority of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company sells through the USA retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.

Share on Social Networks: